Pacira | PCRX - SCHULD





SCHULD Veränderung Datum
Assertio Holdings USD 38.87M 615K 2023-09
Astellas Pharma JPY 831.43B 83.94B 2025-03
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 45.8B 4.97B 2025-09
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
Nektar Therapeutics USD 0 0 2022-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.64B 7.2M 2025-09
Pfizer USD 60.85B 78M 2025-09
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Xeris Pharmaceuticals USD 257.65M 431K 2025-09
Xoma USD 120.79M 3.27M 2024-06
Zoetis USD 7.27B 482M 2025-09